12th pharmacovigilance stakeholder forum

EventHumanRegulatory and procedural guidancePharmacovigilance

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

Date

Mánudagur, 24 september 2018, All day

Staðsetning

European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and the pharmaceutical industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Video

Documents

Agenda – 12th Pharmacovigilance stakeholder forum

Reference Number: EMA/274125/2018

English (EN) (75.95 KB - PDF)

Fyrst birt: Síðast uppfært:
Skoða

List of participants: 12th stakeholder forum on the pharmacovigilance legislation

Reference Number: EMA/505196/2018

English (EN) (83.22 KB - PDF)

Fyrst birt:
Skoða

Presentation - Pharmacovigilance in 2018 (P. Arlett)

English (EN) (2.56 MB - PDF)

Fyrst birt:
Skoða

Presentation - Overview of current patient involvement (M. Mavris)

English (EN) (1.15 MB - PDF)

Fyrst birt:
Skoða

Presentation - Public Hearings; experience so far (N. Bere)

English (EN) (318.9 KB - PDF)

Fyrst birt:
Skoða

Presentation - The engagement of patients and healthcare professionals in regulatory pharmacovigilance: developing a conceptualisation (P. Brown)

English (EN) (1.18 MB - PDF)

Fyrst birt:
Skoða

Presentation - Valproate case study: industry perspective (E. Teo)

English (EN) (172.44 KB - PDF)

Fyrst birt:
Skoða

Presentation - Public hearing on valproate: Account of events and outcomes (E. Vatzaki)

English (EN) (181.97 KB - PDF)

Fyrst birt:
Skoða

Presentation - Valproate case study: patients' perspective (F.Houyez)

English (EN) (2.84 MB - PDF)

Fyrst birt:
Skoða

Presentation - Valproate case study: pharmacists' perspective (R. Anderson)

English (EN) (892.25 KB - PDF)

Fyrst birt:
Skoða

Presentation - Valproate case study: doctors' perspective (R. Kalvianen)

English (EN) (921.29 KB - PDF)

Fyrst birt:
Skoða

Presentation - Valproate case study: engagement of patients and healthcare professionals (P. Bahri)

English (EN) (245.16 KB - PDF)

Fyrst birt:
Skoða

Presentation - Pharmacovigilance in the next 5 years, doctors' vision (C. Matias)

English (EN) (730.35 KB - PDF)

Fyrst birt:
Skoða

Presentation - Pharmacovigilance in the next 5 years, pharmacists' vision (J. De Belie)

English (EN) (658.34 KB - PDF)

Fyrst birt:
Skoða

Presentation - Pharmacovigilance in the next 5 years, industry vision (V. Edwards)

English (EN) (1.12 MB - PDF)

Fyrst birt:
Skoða

Share this page